|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Hyperglycemia as An Independent Predictor of Worse Outcome in Non-diabetic Patients Presenting with Acute Ischemic Stroke显示文摘 | Latha G. Stead Rachel M. Gilmore M. Fernanda Bellolio Shaily Mishra Anjali Bhagra Lekshmi Vaidyanathan Wyatt W. Decker Robert D. Brown | 2009 | Neurocritical Care2009，，2： | 1 |
| 2 | Total Thyroidectomy for Benign Thyroid Disorders in an Endemic Region显示文摘 | Anjali Mishra Amit Agarwal Gaurav Agarwal S.K. Mishra | 2001 | World Journal of Surgery2001，，3： | 1 |
| 3 | Hyperglycemia as An Independent Predictor of Worse Outcome in Non-diabetic Patients Presenting with Acute Ischemic Stroke显示文摘 | Latha G. Stead Rachel M. Gilmore M. Fernanda Bellolio Shaily Mishra Anjali Bhagra Lekshmi Vaidyanathan Wyatt W. Decker Robert D. Brown | 2009 | Neurocritical Care2009，，2： | 1 |
| 4 | Hyperglycemia as An Independent Predictor of Worse Outcome in Non-diabetic Patients Presenting with Acute Ischemic Stroke显示文摘 | Latha G. Stead Rachel M. Gilmore M. Fernanda Bellolio Shaily Mishra Anjali Bhagra Lekshmi Vaidyanathan Wyatt W. Decker Robert D. Brown | 2009 | Neurocritical Care2009，，2： | 1 |
| 5 | Pattern and Risk Factors of Central Compartment Lymph Node Metastasis in Papillary Thyroid Cancer: A Prospective Study from an Endocrine Surgery Centre显示文摘 | Sudhi Agarwal Gyan Chand Sushila Jaiswal Anjali Mishra Gaurav Agarwal Amit Agarwal A. K. Verma S. K. Mishra Yasuhiro Ito | 2011 | Journal of Thyroid Research2011，，： | 1 |
| 6 | Sp1/NFκB/HDAC/ miR-29b Regulatory Network in KIT-Driven Myeloid Leukemia显示文摘 | Shujun Liu Lai-Chu Wu Jiuxia Pang Ramasamy Santhanam Sebastian Schwind Yue-Zhong Wu Christopher J. Hickey Jianhua Yu Heiko Becker Kati Maharry Michael D. Radmacher Chenglong Li Susan P. Whitman Anjali Mishra Nicole Stauffer Anna M. Eiring Roger Briesewitz | 2010 | Cancer Cell2010，，4： | 1 |
| 7 | Fungal arthritis:A challenging clinical entity显示文摘There has been an increasing incidence of fungal infections in recent years.Rarely joints are also affected by fungal infections.Mainly,these infections develop in prosthetic joints,but sometimes native joints are also involved.Candida infections are mostly reported,but patients may also develop infections secondary to non-Candida fungi,especially Aspergillus.Diagnosis and management of these infections is challenging and may involve multiple surgical interventions and prolonged antifungal therapy.Despite this,these infections are associated with high morbidity and mortality.This review described the clinical features,risk factors,and therapeutic interventions required to manage fungal arthritis. | Anjali Mishra Deven Juneja | 2023 | World Journal of Orthopedics2023，14，2： | 0 |
| 8 | Biomarkers in sepsis-looking for the Holy Grail or chasing a mirage!显示文摘Sepsis is defined as a life-threatening organ dysfunction caused by the dysregulated host response to infection.It is a complex syndrome and is characterized by physiologic,pathologic and biochemical abnormalities in response to an infection.Diagnosis of sepsis is based on history,physical examination and other investigations(including biomarkers)which may help to increase the certainty of diagnosis.Biomarkers have been evaluated in the past for many diseases and have been evaluated for sepsis as well.Biomarkers may find a possible role in diagnosis,prognostication,therapeutic monitoring and anti-microbial stewardship in sepsis.Since the pathophysiology of sepsis is quite complex and is incompletely understood,a single biomarker that may be robust enough to provide all information has not been found as of yet.However,many biomarkers have been studied and some of them have applications at the bedside and guide clinical decision-making.We evaluated the PubMed database to search for sepsis biomarkers for diagnosis,prognosis and possible role in antibiotic escalation and de-escalation.Clinical trials,meta-analyses,systematic reviews and randomized controlled trials were included.Commonly studied biomarkers such as procalcitonin,Soluble urokinase-type plasminogen activator(Supar),presepsin,soluble triggering receptor expressed on myeloid cells 1,interleukin 6,C-reactive protein,etc.,have been described for their possible applications as biomarkers in septic patients.The sepsis biomarkers are still an area of active research with newer evidence adding to the knowledge base continuously.For patients presenting with sepsis,early diagnosis and prompt resuscitation and early administration of anti-microbials(preferably within 1 h)and source control are desired goals.Biomarkers may help us in the diagnosis,prognosis and therapeutic monitoring of septic patients.The marker redefining our view on sepsis is yet a mirage that clinicians and researchers continue to chase. | Neelmani Ahuja Anjali Mishra Ruchi Gupta Sumit Ray | 2023 | World Journal of Critical Care Medicine2023，12，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员